课题基金 / 基金详情

Mild and Selective Cooperative-Base Mediated Hydrosilylations for Improved Drug Synthesis

Mild and Selective Cooperative-Base Mediated Hydrosilylations for Improved Drug Synthesis
温和选择性合作介导的氢化硅烷化用于改进药物合成
批准号:
10436072
负责人:
Gregory W O'Neil
金额:
$37.6万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-04-01 至 2025-03-31

项目摘要

项目成果

Gregory W O'Neil的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract PI: Gregory O’Neil Western Washington University Title: Mild and Selective Cooperative-Base Mediated Hydrosilylations for Improved Drug Synthesis Abstract: Reduction reactions are key transformations in the synthesis of both clinical and experimental drugs used to treat various human diseases. Common reducing agents, however, can present certain hazards (e.g. sensitivity to moisture and the release of flammable H2 gas) and/or require special handling and equipment. Additionally, as the target molecules become more complex, selectivity requirements become more stringent which drives the need for new easily performed and highly selective reduction protocols. This proposal describes the use of organosilanes combined with cooperative-base activation to produce a mild, approachable, and selective reduction method with which to access various biologically active molecules. Both substrate-controlled diastereoselective hydrosilylations and chiral base-mediated enantioselective carbonyl reductions will be investigated. The intramolecularity of these reactions is also expected to render the transformations chemoselective (Aim #1). Regioselective epoxide openings will be accomplished that may feature newly designed silanes and/or Lewis base activators (Aim #2). All of these reactions are expected to generate dioxasilinane products that can then be further functionalized to generate valuable synthetic intermediates that would otherwise be challenging to prepare (Aim #3). This is to be achieved by pursuing the following specific aims: 1. Explore chemo-, regio-, and diastereoselective cooperative base-mediated intramolecular hydrosilylations. 2. Perform mechanism-based optimizations of intramolecular hydrosilylations. 3. Investigate functionalization reactions of dioxasilinane intramolecular hydrosilylation products. This work will have a significant positive impact on providing new and superior access to various important synthetic intermediates through the combination of predictable selectivity, versatility, and mild reaction conditions, as well as presenting significant training opportunities for undergraduate participants in various research methods.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Probing the Archazolid Pharmacophore Using Plant-Based V-ATPase Assays
  • 批准号:
    8290763
  • 项目类别:
  • 资助金额:
    $29.03万
  • 财政年份:
    2012
  • 负责人:
    Gregory W O'Neil
  • 依托单位:
国内基金
海外基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data